Elanco GC buys 3,998 shares at $23.58 each

Elanco Animal Health Inc (ELAN) reported that officer Shiv O'Neill, General Counsel and Corporate Secretary, purchased 3,998 shares of common stock on 2026-08-18 at $23.58 per share in an open-market or private transaction.

Rhea-AI Filing Summary

Elanco Animal Health Inc (ELAN) reported that officer Shiv O'Neill, General Counsel and Corporate Secretary, purchased 3,998 shares of common stock on 2026-08-18 at $23.58 per share in an open-market or private transaction. After this trade, O'Neill directly holds 87,832 shares of Elanco common stock. The transaction was not made pursuant to a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Buyer: 3,998 shares

Net Buy 1 txn

Insider O'Neill Shiv

Role GC AND CORP SEC

Bought 3,998 shs ($94K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	3,998	$23.58	$94K

Holdings After Transaction: Common Stock — 87,832 shares (Direct)

Key Figures

Shares purchased: 3,998 shares Purchase price per share: $23.58 per share Shares owned after transaction: 87,832 shares

3 metrics

Shares purchased 3,998 shares Common stock purchased on 2026-08-18

Purchase price per share $23.58 per share Price for the 2026-08-18 common stock purchase

Shares owned after transaction 87,832 shares Direct common stock holdings following the reported trade

Key Terms

Rule 10b5-1, open-market or private transaction, beneficial ownership

3 terms

Rule 10b5-1 regulatory

"The transaction was not made pursuant to a Rule 10b5-1 trading plan."

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open-market or private transaction market

"transaction code description shows a purchase in an open-market or private transaction."

beneficial ownership financial

"direct holdings reflect the insider’s beneficial ownership of common stock."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ELAN report for Shiv O'Neill?

Elanco (ELAN) reported that officer Shiv O'Neill bought 3,998 shares of common stock on 2026-08-18 at $23.58 per share. This was an open-market or private purchase and increased O'Neill’s direct holdings.

How many ELAN shares does Shiv O'Neill hold after this transaction?

After the reported purchase, Shiv O'Neill directly holds 87,832 shares of Elanco (ELAN) common stock. This figure represents O'Neill’s direct ownership position following the 3,998-share open-market or private transaction.

At what price were the ELAN shares purchased by Shiv O'Neill?

3,998 ELAN shares were purchased at $23.58 per share by officer Shiv O'Neill. The filing describes the transaction code as a purchase in an open-market or private transaction, with the reported price on a per-share basis.

Was the recent ELAN insider trade under a Rule 10b5-1 plan?

No. The filing for Elanco (ELAN) indicates the Rule 10b5-1 checkbox is not marked, meaning this transaction was not affirmed as executed under a Rule 10b5-1 trading plan, but rather reported as a regular open-market or private purchase.

What role does Shiv O'Neill hold at Elanco (ELAN)?

According to the filing, Shiv O'Neill is an officer of Elanco (ELAN) serving as General Counsel and Corporate Secretary. The reported 3,998-share purchase reflects trading activity in that executive capacity with direct ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:32 PM Accepted by SEC EDGAR 08/18/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neill Shiv

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC AND CORP SEC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2026		P		3,998	A	$23.58	87,832	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24-Power of Attorney

	/s/ Amy C. Seidel, as Attorney-in-Fact for Shiv O'Neill	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)